AstraZeneca investors to revolt against CEO Pascal Soriot’s pay yet again: report
AstraZeneca investors are once again taking issues with CEO Pascal Soriot’s compensation package, just like they have repeatedly in the past few years. Institutional investors in London are planning to vote against AZ’s remuneration report and policy at its annual meeting on April 29, Sky News reported. This time, despite the company’s stellar financial performance… Read More »